These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11562850)

  • 1. [Profile of Alzheimer's disease in women].
    Villarroya-Pastor MT
    Rev Neurol; 2001 Jun 16-30; 32(12):1178-81. PubMed ID: 11562850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estrogens and Alzheimer disease].
    Stähelin HB
    Schweiz Med Wochenschr; 1999 Dec; 129(49):1920-5. PubMed ID: 10635084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.
    Tang MX; Jacobs D; Stern Y; Marder K; Schofield P; Gurland B; Andrews H; Mayeux R
    Lancet; 1996 Aug; 348(9025):429-32. PubMed ID: 8709781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB
    Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: an estrogen link?
    Beckmann CR
    Curr Opin Obstet Gynecol; 1997 Oct; 9(5):295-9. PubMed ID: 9360809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline.
    Gibbs RB; Aggarwal P
    Horm Behav; 1998 Oct; 34(2):98-111. PubMed ID: 9799621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurobiology and pharmacotherapy of Alzheimer's disease.
    Felician O; Sandson TA
    J Neuropsychiatry Clin Neurosci; 1999; 11(1):19-31. PubMed ID: 9990552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women.
    Corbo RM; Gambina G; Ulizzi L; Moretto G; Scacchi R
    Dement Geriatr Cogn Disord; 2009; 27(6):513-8. PubMed ID: 19478482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease?
    Pomponi MF; Gambassi G; Pomponi M; Di Gioia A; Masullo C
    Ageing Res Rev; 2011 Jan; 10(1):124-31. PubMed ID: 20920611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease.
    Greene RA
    Int J Fertil Womens Med; 2000; 45(4):253-7. PubMed ID: 10997480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
    Henderson VW
    Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alzheimer's disease and women].
    Alberca R; Montes-Latorre E; Gil-Néciga E; Mir-Rivera P; Lozano-San Martín P
    Rev Neurol; 2002 Sep 16-30; 35(6):571-9. PubMed ID: 12389175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease, apolipoprotein E and hormone replacement therapy.
    Depypere H; Vierin A; Weyers S; Sieben A
    Maturitas; 2016 Dec; 94():98-105. PubMed ID: 27823753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogens and hormone replacement therapy: is there a role in the preservation of cognitive function?
    Bieber EJ; Cohen DP
    Int J Fertil Womens Med; 2001; 46(4):206-9. PubMed ID: 11563830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease.
    Candore G; Balistreri CR; Grimaldi MP; Vasto S; Listì F; Chiappelli M; Licastro F; Lio D; Caruso C
    Ann N Y Acad Sci; 2006 Nov; 1089():472-86. PubMed ID: 17261790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk factors in Alzheimer's disease.
    Fehér A
    Ideggyogy Sz; 2010 Sep; 63(9-10):328-34. PubMed ID: 21033314
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic features of menopausal and postmenopausal applicants for life insurance.
    Schiefeling M
    J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.